Mesenteric Surgical Margin for Crohn's Disease Endoscopic Recurrence
NCT06241170 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 172
Last updated 2025-07-15
Summary
Despite significant advancements in the treatment of Crohn's disease (CD), approximately 50% of patients undergo surgical intervention within ten years of diagnosis. Furthermore, more than 70% of these patients experience endoscopic recurrence within one year after surgery. This subset of patients often faces a poorer long-term prognosis and requires long-term intensified medical therapy. Therefore, reducing early postoperative endoscopic recurrence has remained a crucial focus in CD research.
From a surgical perspective, there have been limited breakthroughs in improving surgical techniques to reduce the postoperative endoscopic recurrence rate in CD. Recent research indicates that microscopic inflammation at the cut edge of the CD bowel segment is a significant risk factor for postoperative endoscopic recurrence. Mesenteric wrapping is a unique clinical pathological feature of CD. Our retrospective data suggest a clear linear correlation between the degree of mesenteric wrapping and microscopic inflammation in the corresponding bowel segment. Surgical margins determined by mesenteric guidance significantly reduce the postoperative endoscopic recurrence rate and clinical relapse rate compared to the traditional 2 cm margin. However, there is currently no prospective study comparing the efficacy of these two surgical approaches.To address this, investigators plan to conduct a multicenter randomized controlled trial. This trial will focus on patients with ileocolonic CD who have undergone primary anastomosis without residual disease. investigators aim to compare the postoperative endoscopic recurrence rates between mesenteric-guided margins and the traditional 2 cm margins. Our goal is to determine whether mesenteric-guided margins can reduce the postoperative endoscopic recurrence rate and to conduct relevant mechanistic research. Ultimately, this research may lead to the development of a novel surgical approach for CD based on the findings of this study.
Conditions
- Endoscopic Recurrence Rate
- After Ileocolic Crohn 's Disease Surgery
Interventions
- PROCEDURE
-
mesentery-guided resection margin
Mesentery-guided resection margin where the mesentery adjacent to the intestine completely transitions from abnormal to normal upon palpation and transillumination, compared to the proximal normal mesentery. Open, laparoscopic, hand-assisted, or robotic mobilization are all acceptable, but extracorporeal resection and anastomosis are required. After intestinal mobilization , the diseased intestinal segment is exteriorized from the abdominal cavity.
- PROCEDURE
-
traditional resection margin
2 cm proximal to the site where gross lesions disappear. After transecting the bowel, re-examine the mucosal condition; if mucosal ulcers or obvious scars are present, extend the incision until reaching the site with normal mucosa. Definition of gross lesions: Evaluation from the outer intestinal wall: The site where the tough texture, thickening, or contracture at the mesenteric edge of the intestinal wall disappears; evaluation from the intestinal lumen: The site where mucosal ulcers, fissures, or obvious scars disappear. "Mucosa appearing seemingly abnormal" is considered normal.
Sponsors & Collaborators
-
Jinling Hospital, China
collaborator OTHER -
Sir Run Run Shaw Hospital
collaborator OTHER -
Zhongnan Hospital
collaborator OTHER -
Sixth Affiliated Hospital, Sun Yat-sen University
lead OTHER
Principal Investigators
-
Jia Ke, M.D. · Sixth Affiliated Hospital, Sun Yat-sen University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 14 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-01
- Primary Completion
- 2028-12-31
- Completion
- 2031-12-31
Countries
- China
Study Locations
More Related Trials
-
Safety of Mesentery-embedding Surgery in Patients With Ileocolic Crohn's Disease on Biotherapy
NCT06856044 ·Status: RECRUITING ·Phase: NA
-
Postoperative Progression of the Disease Following Extensive Versus Limited Mesenteric Excision for Crohn's Disease
NCT03769922 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Two Stapled Antimesenteric Anastomosis for CD: a Randomized Control Trial Study
NCT05658081 ·Status: RECRUITING ·Phase: NA
-
Minimally Invasive Surgery in Crohn's Disease: Laparoscopic vs Robotic
NCT05161442 ·Status: COMPLETED
-
Early Bowel Resection for Terminal Ileal Crohn's Disease
NCT06116604 ·Status: RECRUITING
-
Impact of Disease Activity and Nutrition Treat on Postoperative Recurrence and Complications After Bowel Resection for Crohn's Disease
NCT01540942 ·Status: COMPLETED ·Phase: NA
-
Active Surgical Intervention on Crohn's Disease
NCT05523050 ·Status: UNKNOWN ·Phase: NA
-
Endoscopic Relapse Risks Evaluation After Ileocolic Resection for Crohn's Disease
NCT06299631 ·Status: COMPLETED
-
Endoscopic Stricturotomy Versus Endoscopic Balloon Dilatation in Patients With Crohn's Disease and Symptomatic Small Bowel Stricture
NCT05009212 ·Status: RECRUITING ·Phase: NA
-
Extensive Mesenteric Excision (EME) Versus Local Mesenteric Excision (LME) for Crohn's Disease
NCT02542904 ·Status: COMPLETED ·Phase: NA
-
Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis
NCT03256240 ·Status: RECRUITING ·Phase: NA
-
AI-Assisted MRE for Intestinal Fibrosis in Crohn's Disease
NCT06858553 ·Status: RECRUITING
-
Cellvizio to Evaluate Margins in Crohn's Ileal Disease
NCT05805020 ·Status: RECRUITING ·Phase: NA
-
Effectiveness of Rifaximin on Preventing Postoperative Recurrence in Crohn's Disease
NCT03185624 ·Status: UNKNOWN ·Phase: PHASE3
-
Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease
NCT04266600 ·Status: UNKNOWN ·Phase: NA
-
Mesenteric Sparing for the Prevention of Recurrent Crohn's Disease
NCT03172143 ·Status: TERMINATED ·Phase: NA
-
Prediction and Close Monitoring of Postoperative Recurrence by Intestinal Ultrasound After Ileocecal Resection in Crohn's Disease Patients
NCT05713409 ·Status: UNKNOWN
-
Exclusive Enteral Nutrition for Remissionof Crohn's Diseases After Surgery
NCT05214430 ·Status: COMPLETED ·Phase: NA
-
The Remeasure Trial
NCT07164209 ·Status: COMPLETED ·Phase: NA
-
Intraoperative Ultrasound in Crohn's Disease
NCT06388057 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Comparing the Quality of Life of Terminal Ileitis Patients With Crohn's Disease Treated With Anti-TNF or Surgical Resection
NCT02872506 ·Status: WITHDRAWN ·Phase: NA
-
AI-enabled Endoscopic Prediction of Post-operative Recurrence in Crohn's Disease
NCT06505304 ·Status: RECRUITING
-
The Efficacy of Enteral Nutrition in Fill of the Treatment Blank Period of the Postoperative Maintain Remission Medication for Crohn's Disease (CD)
NCT01823042 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study on the Distribution of Digestive Tract Microbiota Before and After Ileocecal Resection in Crohn's Disease
NCT05615116 ·Status: UNKNOWN
-
The Diagnostic Methods of Early Postoperative Flare-up of Crohn's Disease
NCT02578576 ·Status: UNKNOWN